Data Driven Bioscience is building a faster, cheaper sequencing-based way to diagnose and subtype cancers, starting with lymphoma.
Data Driven Bioscience, which trades as Duoseq, develops sequencing-based diagnostic assays that read DNA and RNA together to classify cancers more precisely and at lower cost than current pathology workups, with early work in lymphoma subtyping. Its YC pitch was cancer diagnosis ten times faster and ten times cheaper. The company is a Duke University area spin-out and remains active in the YC directory; published clinical validation is limited, so treat the evidence as early.
Shares Y Combinator, RNA sequencing & expression profiling, Comprehensive genomic profiling and the tag yc.
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.
Shares Y Combinator, Comprehensive genomic profiling and the tag yc.
Shares Y Combinator, RNA sequencing & expression profiling and the tag yc.